Latest statistics and disclosures from Braslyn's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are Inseego, TNGX, and represent 100.00% of Braslyn's stock portfolio.
  • Reduced shares in these 2 stocks: Mirati Therapeutics (-$184M), Inseego (-$19M).
  • Sold out of its position in Mirati Therapeutics.
  • Braslyn was a net seller of stock by $-203M.
  • Braslyn has $2.3M in assets under management (AUM), dropping by -98.74%.
  • Central Index Key (CIK): 0001642355

Tip: Access up to 7 years of quarterly data

Positions held by Braslyn consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Braslyn

Braslyn holds 2 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Inseego Corp Common 90.9 $2.1M -90% 762k 2.80
 View chart
Tango Therapeutics Common (TNGX) 9.1 $214k 27k 7.94
 View chart

Past Filings by Braslyn

SEC 13F filings are viewable for Braslyn going back to 2023